Swiss pharma giant Novartis is taking legal action against the Australian cancer care provider as a dispute over how to fund ...

Beyoncé’s dad teamed up with ZERO Prostate Cancer to tackle the disease. Learn how this game-changing campaign is breaking stigma, expanding screenings and saving lives.

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that its prostate cancer PET[1] imaging agent Illuccix® ...

During this time, Novartis also had many breakthroughs in the pharmaceuticals sector. One of the most significant advanced in cancer treatment in the first decade of the 21st century was Glivec ...

Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Key biosimilar value driver contributes to Sandoz global growth strategy and moves company closer to becoming #1 in biosimilars ...

Samsung Bioepis Co., Ltd. today announced that PYZCHIVA® (ustekinumab-ttwe), a biosimilar to Stelara (ustekinumab), is now available in the United States. PYZCHIVA has been approved for the treatment ...

Like other developers of recently approved gene therapies, Bluebird has been slow to generate demand for its products. That reflects challenges in securing reimbursement from payers stemming from ...